Because aberrant DNA methylation has frequently been identified in recurrent GBM,27 we treated U87MG cells with the DNA methylation inhibitor 5-aza-cytidine and found that CYP17A1 expression was markedly increased after the inhibition of DNA methylation (Figure 4a). This evidence concerns the gene CYP17A1 and glioblastoma.